Table 1.
Patients' baseline characteristics (n = 246).
| Characteristics | n (%) |
|---|---|
| Age, years (mean ± SD) | 5.39 ± 5.4 |
| Age category | |
| Child | 121 (49.2) |
| Infant | 125 (50.8) |
| Sex | |
| Female | 137 (55.7) |
| Male | 109 (44.3) |
| Weight, kg (mean ± SD) | 19.8 ± 18.4 |
| Reason for admission | |
| Gastrointestinal disorders | 60 (24.4) |
| Infectious and inflammatory disorders | 39 (15.9) |
| Respiratory disorders | 28 (11.4) |
| Cardiovascular disorders | 25 (10.2) |
| Metabolic complications | 19 (7.7) |
| Neurological disorders | 3 (1.2) |
| Others | 66 (26.8) |
| No data available | 6 (2.4) |
| Comorbidities (n = 173a) | |
| Heart diseases | 32 (18.5) |
| Seizure | 16 (9.3) |
| Lung diseases | 16 (9.3) |
| Type 1 diabetes | 15 (8.7) |
| Liver and spleen diseases | 12 (6.9) |
| Down syndrome | 11 (6.4) |
| Anemia | 9 (5.2) |
| Gastroesophageal reflux disease | 8 (4.6) |
| Eczema and skin rash | 7 (4.0) |
| Gastrointestinal bleeding | 3 (1.7) |
| Others | 44 (25.4) |
| Medication history (n = 119b) | |
| Insulins | 32 (26.9) |
| Diuretics | 15 (12.6) |
| Iron or multivitamin supplements | 12 (10.1) |
| Blood pressure medications | 10 (8.4) |
| Anticonvulsants | 9 (7.6) |
| Steroids | 6 (5.0) |
| Analgesics | 5 (4.2) |
| Barbiturates | 4 (3.4) |
| Benzodiazepines | 4 (3.4) |
| Others | 22 (18.5) |
Data are presented as numbers (%) unless stated otherwise.
Abbreviations, n, number of samples, SD, standard deviation.
a
The total number indicates the total number of comorbidities, and patients might have more than one comorbidity.
b
The total number indicates the total medications, and a patient might have more than one medication.